Connect Biopharma Holdings Limited Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Connect Biopharma Holdings Limited stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $176.00K, a 23.08% increase year-over-year.
- Connect Biopharma Holdings Limited stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $143.00K, a 615.00% increase year-over-year.
- Connect Biopharma Holdings Limited stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $20.00K.
- Connect Biopharma Holdings Limited stock issued during period, value, employee stock purchase plan for fiscal 2025 was $218.00K, a 560.61% increase from fiscal 2024.
- Connect Biopharma Holdings Limited stock issued during period, value, employee stock purchase plan for fiscal 2024 was $33.00K, a 25.00% decline from fiscal 2023.
- Connect Biopharma Holdings Limited stock issued during period, value, employee stock purchase plan for fiscal 2023 was $44.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $176.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $218.00K 10-K · filed 2026-03-31 | |
| 2025-06-30 | $143.00K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $33.00K 10-K · filed 2026-03-31 | |
| 2024-06-30 | $20.00K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $44.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |